Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team

Throne Biotechnologies

Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team
February 11, 2017
Throne Biotechnologies

The Ministry of Science and Technology of China funded the Stem Cell Educator Therapy for the Treatment of Children with Type 1 Diabetes.

February 11, 2017
Throne Biotechnologies

The Ministry of Science and Technology of China funded the Stem Cell Educator therapy for the treatment of children with type 1 diabetes. This project is an international collaboration between Dr. Yong Zhao at Hackensack University Medical Center (USA) and Dr. Zhiguang Zhou at Central South University (China).  

February 11, 2017
Throne Biotechnologies

Throne Biotechnologies

Dr.Zhao and his team published four-year follow-up studies demonstrated the long-term safety and clinical efficacy of Stem Cell Educator therapy for the treatment of type 1 diabetes (T1D) and T2D.
The FDA-approved clinical trial of Stem Cell Educator therapy is started to treat type 1 diabetic patients at Hackensack University Medical Center.

Paramus, New Jersey - New York City Metro

connect@thronebio.com

Back To Top
 

Life is in

Throne logo mark - full color.png
 

the Blood

© 2025 Throne Biotechnologies Inc., All rights reserved.